KRAS and pancreatic neoplasm: NIK is elevated in pancreatic cancer and associated with increased proliferation [61,62] and up-regulation of RelB and p52 are associated with mutated KRAS pancreatic cancer [63] with IKKα dependent gene expression being observed [51].